ANZDATA Registry Publications.
Chang SH, Russ GR, Chadban SJ,
Campbell SB & McDonald SP:
Trends in adult post-kidney transplant immunosuppressive use in
Australia, 1991-2005.
Nephrology (In Press).
Badve SV, Hawley CM,
McDonald SP, Mudge DW, Rosman JB, Brown FG & Johnson DW:
Automated and continuous ambulatory peritoneal dialysis have similar
outcomes.
Kidney Int, 2007.
Lim WH, Chang SH, Coates PT &
McDonald SP:
Parental donors in live-donor kidney transplantation associated with
increased rejection rates and reduced glomerular filtration rates.
Transplantation, 84: 972-80, 2007.
Villar E, Chang SH & McDonald SP:
Incidences, treatments, outcomes, and gender effect on survival in end-stage
renal disease patients by diabetic status in Australia and New Zealand
(1991-2005).
Diabetes Care, 30: 3070, 2007.
Chang SH, Coates PT & McDonald SP:
Effects of body mass index at transplant on outcomes of kidney
transplantation.
Transplantation, 84: 981-7, 2007.
Moist LM, Chang SH, Polkinghorne KR &
McDonald SP:
Trends in hemodialysis vascular access from the Australia and New Zealand
Dialysis and Transplant Registry (ANZDATA) 2000 to 2005.
Am J Kidney Dis, 50: 612-21, 2007.
McDonald SP, Russ GR, Campbell SB & Chadban S:
Kidney Transplant Rejection in Australia and New Zealand: Relationships
between rejection and graft outcome.
Am J Trans, 7: 1201-6, 2007.
Chang SH, Russ GR, Chadban SJ,
Campbell SB & McDonald SP:
Trends in Kidney Transplantation in Australia and New Zealand, 1993-2004.
Transplantation, 84: 611-618, 2007.
Craven A.-M.S., Hawley C.M., McDonald S.P., Rosman J.B., Brown F.G., and
Johnson D.W.
Predictors of renal recovery in Australian and New Zealand end-stage
renal failure patients treated with peritoneal dialysis.
Perit Dial Int, 2007. 27(2): p. 184-191.
Wiggins KJ, McDonald SP,
Brown FG, Rosman JB & Johnson DW:
High membrane transport status on peritoneal dialysis is not
associated with reduced survival following transfer to haemodialysis.
Nephrol
Dial Transplant, 22: 3005-12,
2007.
Badve SV, Hawley CM, McDonald SP, Mudge DW, Rosman JB,
Brown FG, Johnson DW, for The ANZDATA Registry P. D. Working Committee.
Effect of previously failed kidney transplantation on peritoneal
dialysis outcomes in the Australian and New Zealand patient populations.
Nephrol Dial Transplant 2006;21(3):776-83.
Marshall MR, Byrne BG, Kerr PG, McDonald SP.
Associations of haemodialysis dose and session length with mortality risk
in Australian and New Zealand patients.
Kidney Int 2006;69(7):1229–36.
McDonald SP, Russ GR.
Recurrence of IgA Nephropathy Among Renal Allograft Recipients From
Living Donors is Greater Among Those With Zero HLA Mismatches.
Transplantatino 2006;82(6):759-62.
Stewart JH, McCredie MR, Williams SM, Fenton SS, Trpeski
L, McDonald SP, Jager KJ, van Dijk PC, Finne P, Schon S, Leivestad T,
Lokkegaard H, Billiouw JM, Kramar R, Magaz A, Vela E, Garcia- Blasco MJ,
Ioannidis GA, Lim YN.
The enigma of hypertensive ESRD: observations on incidence and trends in
18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.
Am J Kidney Dis 2006; 48(2):183-91.
Irving M, Craig JC, Roger S, McDonald SP, Gallagher MP,
Polkinghorne K, Mathew T, Walker R.
Implementation of clinical practice guidelines: variability in
implementation of iron management guidelines in chronic kidney disease
patients on dialysis.
Med J Aust 2006;185(6):310-6.
Kennedy SE, Mackie FE, Rosenberg AR, McDonald SP.
Waiting Time and Outcome of Kidney Transplantation in Adolescents.
Transplantation 2006;In Press.
The ESRD Incidence Study Group.
Geographic, ethnic, age-related and temporal variation in the incidence
of end-stage renal disease in Europe, Canada and the Asia-Pacific
region, 1998-2002.
Nephrol Dial Transplant 2006;21(8):2178-83.
Rumpsfeld M, McDonald SP, Johnson DW.
Higher Peritoneal Transport Status Is Associated with Higher Mortality
and Technique Failure in the Australian and New Zealand Peritoneal
Dialysis Patient Populations.
J Am Soc Nephrol 2006;17(1):271-8.
Lim WH, McDonald SP, Russ GR.
Effect on graft and patient survival between shipped and locally
transplanted well-matched cadaveric renal allografts in Australia over a
10-year period.
Nephrology (Carlton) 2006;11(1):73-7.
Vajdic CM, McDonald SP, McCredie MRE, van Leeuwen MT,
Stewart JH, Law M, Chapman JR,Webster AC, Kaldor JM, Grulich AE.
Cancer Incidence Before and After Kidney Transplantation.
JAMA 2006;296(23):2823-31.
Faull RJ, Hollett P, McDonald SP.
Lymphoproliferative disease following renal transplantation in Australia
and New Zealand.
Transplantation 2005;80(2):193-7.
Lim WH, Johnson DW, McDonald SP.
Higher rate and earlier peritonitis in Aboriginal patients compared to
non-Aboriginal patients with end-stage renal failure maintained on
peritoneal dialysis in Australia: analysis of ANZDATA.
Nephrology (Carlton) 2005;10(2):192-7.
McDonald S, McCredie M, Williams S, Stewart J.
Factors influencing reported rates of treated end-stage renal disease.
Adv Chronic Kidney Dis 2005;12(1):32-8.
Verran D, Sheridan A, Barnwell A, Berriman M, Chapman J.
Biopsy of potential cadaveric renal allografts at the time of retrieval.
Nephrology (Carlton) 2005;10(4):414-7.
Pond F, Serpell JW, Webster A.
Thyroid cancer in the renal transplant population: epidemiological
study.
ANZ J Surg 2005;75(3):106-9.
Li
SQ, Cunningham J, Cass A.
Renal-related deaths in
Intern Med J.
2004;34:259-265.
Lim WH.
Is there a role for peritoneal dialysis in remote aboriginal patients
with end-stage renal disease in Australia?
Nephrology (Carlton) 2004; 9:S126-8.
McDonald S.
Indigenous transplant outcomes in Australia: What the ANZDATA Registry
tells us.
Nephrology (Carlton) 2004; 9 Suppl 4:S138-43.
McDonald
S, Collins J, Rumpsfeld M, Johnson D.
Obesity is a risk factor for
peritonitis in the Australian and New Zealand peritoneal dialysis
patient populations.
Perit Dial
Int. 2004;24:340-346.
McDonald
SP, Craig JC.
Long term survival of children with end-stage renal
disease.
N Engl J Med.
2004;350:2654-2662.
McDonald
SP, Marshall MR, Kerr PG, Russ GR.
Erythropoietic agents, iron and
hemoglobin - What happens beyond the trial setting: Observational data
from the ANZDATA Registry. Hemodialysis
Int. 2004;8:257-264.
Polkinghorne
KR, McDonald SP, Atkins RC, Kerr PG.
Vascular access and all-cause
mortality: a propensity score analysis.
J
Am Soc Nephrol. 2004;15:477-86.
Rumpsfeld
M, McDonald SP, Purdie DM, Collins J, Johnson DW. Predictors of
baseline peritoneal transport status in Australian and
Am J
Kidney Dis. 2004;43:492-501.
Stewart
JH, McCredie MRE, McDonald SP.
The incidence of treated end-stage
renal disease in New Zealand Maori and
Nephrol
Dial Transplant. 2004;19:678-85.
Stewart
JH, McCredie MR, McDonald SP.
Incidence of end-stage renal disease in
overseas-born, compared with Australian-born, non-indigenous
Australians.
Nephrology
2004; 9:247-252.
Stewart JH, McCredie MR, Williams SM, McDonald SP.
Interpretating Incidence Trends for treated End-Stage Renal
Disease: Implications
Nephrology
2004; 9:238-246.
Cass A, Cunningham J, Snelling P, Wang Z, Hoy W.
Urban disadvantage
and delayed nephrology referral in Australia.
Health
Place. 2003;9:175-82.
Cass A, Cunningham J, Snelling P, Ayanian JZ.
Late referral to a nephrologist reduces access to renal transplantation.
Am
J Kidney Dis. 2003;42:1043-9.
Chapman J, Russ G.
Geographic variance in access to renal
transplantation in
Transplantation.
2003;76:1403-6.
Li SQ, Cass A, Cunningham J.
Cause of death in patients with
end-stage renal disease: assessing concordance of death certificates
with registry reports.
Aust N Z J
Public Health. 2003;27:419-24.
McDonald SP, Collins J, Johnson DW.
Obesity is associated with
worse peritoneal dialysis outcomes in the Australian and
J Am Soc
Nephrol. 2003;14:2894-2901.
McDonald SP, Russ GR.
Current incidence, treatment patterns and
outcome of end-stage renal disease among indigenous groups in
Nephrology. 2003;
McDonald
SP, Russ GR.
The burden of end stage renal disease (ESRD) among
indigenous peoples in Australia & New Zealand.
Kidney
Int. 2003;63:s123-s127.
Polkinghorne
KR, McDonald SP, Atkins RC, Kerr PG.
Epidemiology of vascular access
in the Australian haemodialysis population.
Kidney
Int. 2003;64:1893-1902.
Polkinghorne KR, McDonald SP, Marshall MR, Atkins RC, Kerr PG.
Vascular access practice patterns in the New Zealand haemodialysis
population.
Am J Kid Dis.
2003;43:696-704.
Am
J Kid Dis In Press
McDonald SP, Russ GR, Collins J, Kerr PG.
ESRD in Australia and New Zealand at the end of the millennium: A
Report from the ANZDATA Registry.
Nephrol
Dial Transplant In Press
McDonald SP, Russ GR.
Survival of recipients of cadaveric kidney transplants compared to dialysis treatment in Australia and New Zealand, 1991-2000.
Nephrology
In Press
McDonald SP, Russ GR.
Prevalence, treatment patterns and outcome of end stage renal disease
among indigenous groups in Australia and New Zealand.
Kidney
Int (suppl) In Press
McDonald SP.
The burden of end stage renal disease (ESRD) among indigenous peoples
in Australia and New Zealand.
Kidney Int
61:2259-2265.
McDonald SP, Russ, GR.
Associations between use of cyclosporine-sparing agents and outcome in
kidney transplant recipients.
Ethn Dis 12:373-378.
Cass A, Cunningham J, Snelling P,
Wang Z, Hoy W.
End-stage renal disease in indigenous Australians: a disease
of disadvantage.
Med J Aust 177:135-138.
Cass A, Cunningham J, Arnold PC, Snelling P, Wang Z, Hoy W.
Delayed referral to a nephrologist: outcomes among patients who
survive at least one year on dialysis.
Nephrol Dial Transplant 17:1099-1104.
Briganti EM, Wolfe R, Russ GR,
Eris JM, Walker RG, McNeil JJ.
Graft loss following renal transplantation in Australia: is there a
centre effect?
N Engl J Med 347:103-109.
Briganti EM, Russ GR, McNeil JJ,
Atkins RC, Chadban SJ.
Risk of renal allograft loss from recurrent
glomerulonephritis.
Transplant Proc 33:3400-3402.
Mathew TH, McDonald SP, Russ GR.
Donor and recipient risk factors and choice of immunosuppression
determine long-term outcome in renal transplantation.
Transplant Proc 33:1830-1831.
Chapman
JR, Sheil AG, Disney AP.
Recurrence of cancer after renal transplantation.
Med J Aust 175:24-27.
Cass
A, Cunningham J, Wang Z, Hoy W.
Regional variation in the incidence of end-stage
renal disease in Indigenous Australians.
Aust N Z J Public Health 25:322-326.
Cass
A. Cunningham J, Wang Z, Hoy W.
Social disadvantage and variation in the
incidence of end-stage renal disease in Australian capital cities.
Nephrol
Dial Transplant 16:1364-1367.
Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS,
Sinclair R, McNeil JJ, Atkins RC.
The incidence of biopsy-proven glomerulonephritis
in Australia.
Clin
Transpl 346-348.
Russ GR.
Renal transplantation in Australia and New
Zealand 1963 to 1999.
Transplant Proc 31:1102-1103.
Mathew
TH.
Optimal long-term immunotherapy protocols.
Med J Aust 171:407-410.
Cass
A, Gillin AG, Horvath JS.
End-stage renal disease in Aboriginals in New
South Wales: a very different picture to the Northern Territory.
Am J Kidney Diseases
Patrick Maisonneuve, Lawrence Agodoa, Ryszard Gellert, John H Stewart,
Gherardo Buccianti, Albert B Lowenfels, Robert
A Wolfe, Elisabeth Jones, Alex PS Disney, Douglas Briggs,
Margaret McCredie and Peter Boyle
Distribution of primary renal diseases leading to end stage
renal failure in the United States, Europe, and Australia and New
Zealand: results from an International collaborative study.
Aust N S J Public Health
23:464-467.
Brameld KJ, Thomas MA, Holman CD, Bass AJ, Rouse IL.
Validation of linked administrative data on end-stage renal
failure: application of record linkage to a ‘clinical base
population’.
Transplantation and Nephrology
AD Hibberd, PR Trevillian, JH Wlodarzcyk, AHB Gillies, AM Stein, AGR
Sheil, APS Disney.
Cancer risk associated with ATG/OKT3 in renal transplantation.
Nephrol Dial Transplant
13:854-859.
Alexander P.S. Disney.
Some trends in chronic renal replacement therapy in Australia and New
Zealand. 1997.
Lancet 354:93-99.
Patrick Maisonneuve, Lawrence Agodoa, Ryszard Gellert, John H Stewart,
Gherardo Buccianti, Albert B Lowenfels, Robert A Wolfe, Elisabeth
Jones, Alex PS Disney, Douglas Briggs, Margaret McCredie, Peter
Boyle.
Cancer
in patients on dialysis for end-stage renal disease: an international
collaborative study.
Transplant
Proc 29:825-827.
A.G.R. Sheil, A.P.S. Disney, T.H.
Mathew, B.E.R. Livingston and A.M. Keogh.
Lymphoma incidence, cyclosporine, and the evolution and
major impact of malignancy following organ transplantation.
N Z Med J 110:202-204.
Smith L, Morris M, Wong W.
Renal transplantation in children; the Auckland experience
1980-96.
Contrib Nephrol 111:13-16.
Hartung R, Livingston B, Excell L,
Disney A, Woodroffe AJ.
Recurrence of IgA deposits/disease in grafts. An Australian
Registry survey 1980-1990.
Aust N Z J Surg 65:27-30.
Dewan PA, McMullin ND, Barker AP.
Renal allograft survival in patients with congenital
obstruction of the posterior urethra.
Am J Kid Dis 25:165-175.
Alexander PS Disney. For the Australia and New Zealand Dialysis and
Transplant Registry.
Demography and survival of patients receiving treatment for
chonic renal failure in Australia and New Zealand: Report on dialysis
and renal transplantation treatment from the Australia and New Zealand
Dialysis and Transplant Registry.
Nephrology
1:105-111.
A.P.S.Disney.
Report of renal failure treatment in Australia and New
Zealand from the dialysis and transplant registry (ANZDATA).
Aust NZ J Med 24:36-40.
GM Patrick, JF Mahony, APS Disney.
The prognosis for end-stage renal failure in spinal cord
injury and spina bifida - Australia and New Zealand, 1970-1991.
Nephrol Dial Transplant
9:1377-1382.
JH Stewart, M McCredie, APS Disney and TH Mathew.
Trends in incidence of end-stage renal failure in Australia, 1972-1991.
Aust NZ J Med 24:696-700.
JH Stewart, APS Disney, TH Mathew.
Trends in the incidence of end-stage renal failure due to
hypertension and vascular disease in Australia, 1972-1991.
Transplantation 58:565-569.
Mark J Penny, Brian J Nankivell, Alex PS Disney, Karen Blyth, Jeremy R
Chapman.
Renal graft thrombosis. A
survey of 134 consecutive cases.
Clinical Nephrology 41:101-105.
CK Fairley, AGR Sheil, JJ McNeil, AM Ugoni, APS Disney, GG Giles and N
Amiss.
The risk of ano-genital malignancies in dialysis and transplant patients.
Transplant Proc 25:1383-1384.
Sheil AG, Disney AP, Mathew TH, Amiss N.
De novo malignancy emerges as a major cause of morbidity and
late failure in renal transplantation.
Clin
Transpl 6:202-211
LS Roeger, AGR Sheil, APS Disney,
TH Mathew, N Amiss.
Risk factors associated with the development of squamous
cell carcinomas in immunosuppressed renal transplant recipients.
A Report from the Australia and New Zealand Dialysis and Transplant
Registry.
Transplant Proc 24:1946-1947.
Sheil AG, Disney AP, Mathew TH, Amiss N. Excell L.
Malignancy following renal transplantation.
Med
J Aust 157:262-264.
Disney AP.
Complications of immunosuppressive therapy in
transplantation. 1: Neoplasia and infection.
Transplant
Proc 23:1111-1112.
AGR Sheil, APS Disney, TH Mathew, N Amiss and L Excell.
Cancer development in cadaveric donor renal allograft
recipients treated with Azathioprine (AZA) or Cyclosporine (CyA) or
AZA/CyA.
(February) pp 53-56.
Second CJ Hodson Symposium on Reflux Nephropathy, New Zealand.
Ed. Ross R Bailey APS
Disney.
Reflux nephropathy in Australia and New Zealand: prevalence, incidence
and management.
On behalf of The Australia and New Zealand Dialysis and Transplant
Registry
Am J Kidney Dis 15:402-409.
APS Disney
Dialysis treatment in Australia, 1982 - 1988.
On Behalf of Subcommittee for The Australia and New Zealand Dialysis and
Transplant Registry,
Am J Kidney Dis 15:494-499.
APS Disney.
Prescription and practice of dialysis in Australia 1982 -
1988.
On Behalf of Subcommittee for The Australia and New Zealand Dialysis and
Transplant Registry.
Aust N Z J Med 20:684-688, 694.
M McCredie, MS Coates, JM Ford,
APS Disney, JJ Auld, JH Stewart.
Geographical distribution of cancers of the kidney and
urinary tract and analgesic nephropathy in Australia and New Zealand.
Med J Aust 152:245-50.
EM Hodson, JF Knight, AGR Sheil, LP Roy, JP Harris, JR Rogers, MS
Stephen, J Boulas, JF Thompson, M May.
End-stage renal failure in children:
16 years' experience
at one Australian centre.
Clin Nephrol 31:35-39.
McCredie M, JH Stewart, TH Mathew, APS Disney, JM Ford.
The effect of withdrawal of phenacetin-containing analgesics
on the incidence of kidney and urothelial cancer and renal failure.
Clin Transpl
pp 165-73.
APS Disney.
Progress in renal transplantation in Australia during 1975 to 1988.
Am J Kidney Dis 12:85–96.
Timothy Hamish Mathew.
Recurrence of disease following renal transplantation.
(December) pp 104-109.
Proceedings of the First CJ Hodson Symposium on Reflux Nephropathy
(Melbourne). Edited by
Rown G Walker and Priscilla Kincaid-Smith.
TH Mathew and APS Disney.
Reflux nephropathy as a cause of end-stage renal failure.
The scope of the problem.
Transplant Proc 19:2829-2833.
APS Disney.
Effect of cyclosporin A on risk factors in renal
transplantation.
A Report from the Australia and New Zealand Dialysis and Transplant
Registry.
Transplant Proc 19:2214-2216.
AGR Sheil, S Flavel, APS Disney, TH Mathew and BM Hall.
Cancer incidence in renal transplant patients treated with azathioprine
or cyclosporin.
Transplant Proc (Helsinki) 1986.
19:1981-1984.
APS Disney.
Adverse effects of low dose azathioprine (< 2 mg/kg) on
Australian primary graft survival 1978-1984.
Renal Educator 6:19-22.
APS Disney.
ANZDATA (Australia and New Zealand Dialysis and Transplant Registry).
pp 289-290.
Peritoneal Dialysis - Proceedings 2nd International Course on
Peritoneal Dialysis - Vincenza,
Italy 1985.
LA Poole-Warren, APS Disney, K Schindhelm and PC Farrell.
Australian renal transplant experience in CAPD patients.
Clin Transpl
pp 87-92.
APS Disney.
Effect of HLA matching and cyclosporine A in renal transplantation.
World J Surg 30:389-396.
AGR Sheil.
Cancer after transplantation.
REVIEW ARTICLE:
47 refs.
Diabetic Nephropathy 4:183-188.
APS Disney.
Review of survival by treatment of diabetic nephropathy
patients in Australia and New Zealand 1978-1984.
Transplant Proc 17:1685-1688.
AGR Sheil, S Flavel, APS Disney, TH Mathew.
Cancer development in patients progressing to dialysis and renal
transplantation.
Transplant Proc 16:973-978.
APS Disney.
Renal Transplantation in Australia and New Zealand, 1963-1982.
A Report from the Australia and New Zealand Dialysis and
Transplant Registry.
Transplant Proc 16:925-926.
Transplantation 34:183-189.
Cadaver renal transplantation and HLA matching in Australia
from 1971 to 1980.
A Report of the Australian and New Zealand Combined Dialysis and
Transplant Registry.
Med J Aust 1:117-122.
APS Disney, and RL Correll on behalf of a Subcommittee.
Report of the Australian and New Zealand combined Dialysis
and Transplant Registry.
Transplant Proc 9:1133-1136.
AGR Sheil.
Cancer in renal allograft recipients in Australia and New
Zealand.